Fundz

Kazia Raises A$4.5 Million To Progress R&D Programs

PUBLIC · KZIAJan 16, 2023

Round Type

Funding Round

SydneyBiotechnologyHealth Care

Investors

Kazia Shareholder Approval

Description

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce a placement of KZA shares, to institutional and sophisticated investors in Australia, at a price of A$0.11 per share. The placement will raise A$4.5 million (exclusive of costs).

Quick answer

Kazia Therapeutics raised an undisclosed amount in a Funding Round round, dated January 16, 2023. Investors: Kazia Shareholder Approval. Kazia Therapeutics is based in Sydney, New South Wales, Australia.

How much did Kazia Therapeutics raise?
Kazia Therapeutics raised an undisclosed amount in a Funding Round round on January 16, 2023.
Who invested in Kazia Therapeutics?
Kazia Shareholder Approval is named as investors in this round.
What does Kazia Therapeutics do?
Kazia Therapeutics is a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need.
Where is Kazia Therapeutics based and how big is it?
Kazia Therapeutics is based in Sydney, New South Wales, Australia. Fundz records about 2 employees.
Who are the decision-makers at Kazia Therapeutics?
Fundz holds 2 contacts at Kazia Therapeutics, including the Program Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Kazia Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Corista raised $13M on March 1, 2023.
  • Wilson Wolf Manufacturing raised an undisclosed amount on March 1, 2023.
  • Chroma Medicine raised $135M (Series B) on March 1, 2023.
  • SigTuple raised $4.5M (Seed) on March 1, 2023.
  • Aprea Therapeutics raised an undisclosed amount (Funding Round) on February 28, 2023.
  • Tessera Defense & Homeland Security Inc. raised $1.5M (Seed) on February 27, 2023.

Who to call at Kazia Therapeutics, and when

A new round usually means Kazia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kazia Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kazia Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kazia Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kazia Therapeutics

Location

Level 24, Three International Towers

Sydney, New South Wales, Australia

About

Kazia Therapeutics is a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need. The company focuses on innovative drug development and is based in Sydney, Australia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kazia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMichael F., Program Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Kazia Therapeutics's next move

See what Strategic adds

Kazia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.